[Corrigendum] miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α

Int J Oncol. 2023 Jan;62(1):1. doi: 10.3892/ijo.2022.5449. Epub 2022 Nov 4.

Abstract

Subsequently to the publication of the above article, the authors have contacted the Editorial Office to explain that Fig. 7 was published containing an erroneously placed data panel. Specifically, the center panel of the images selected for the invasion assay experiments portrayed in Fig. 7A (i.e., the miR‑382 experiment) was chosen incorrectly, and the authors have requested that this panel be replaced by the panel containing the data that was actually used for the statistical analysis shown in part (B). The revised version of Fig. 7, showing the correct data panel for the miR‑382 experiment in the invasion assay images in part (A), is shown on the next page. The authors can confirm that the change made to this figure does not affect the overall conclusions reported in the study, and all the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of International Journal of Oncology for allowing them the opportunity to publish this additional Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [International Journal of Oncology 61: 126, 2022; DOI: 10.3892/ijo.2022.5416].

Keywords: breast cancer; metabolic reprogramming; microRNA; tumor microenvironment; tumor‑associated macrophages.

Publication types

  • Published Erratum